EL
IBB icon

Essex LLC’s iShares Biotechnology ETF IBB Stock Holding History

Essex LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
1,106
-225
-17% -$38.7K 0.03% 171
2026
Q1 		$225K Sell
1,331
-43
-3% -$7.35K 0.04% 162
2025
Q4 		$232K Buy
+1,374
New +$223K 0.04% 165
2025
Q1 		– Sell
-1,801
Closed -$238K – 172
2024
Q4 		$238K Sell
1,801
-95
-5% -$13.4K 0.05% 152
2024
Q3 		$276K Sell
1,896
-65
-3% -$9.4K 0.06% 140
2024
Q2 		$269K Hold
1,961
– – 0.06% 135
2024
Q1 		$269K Sell
1,961
-177
-8% -$24.2K 0.06% 129
2023
Q4 		$290K Sell
2,138
-605
-22% -$73.8K 0.07% 132
2023
Q3 		$335K Sell
2,743
-828
-23% -$105K 0.09% 116
2023
Q2 		$453K Sell
3,571
-703
-16% -$91.3K 0.13% 100
2023
Q1 		$561K Hold
4,274
– – 0.17% 97
2022
Q4 		$561K Buy
4,274
+31
+0.7% +$4.01K 0.17% 97
2022
Q3 		$496K Sell
4,243
-4,030
-49% -$500K 0.16% 100
2022
Q2 		$973K Buy
8,273
+610
+8% +$72.4K 0.3% 78
2022
Q1 		$998K Buy
7,663
+2,935
+62% +$382K 0.27% 82
2021
Q4 		$722K Buy
4,728
+200
+4% +$31K 0.19% 98
2021
Q3 		$732K Buy
+4,528
New +$762K 0.2% 96

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Essex LLC's IBB Position: Q2 2026 in Review

Essex LLC reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q2 2026, selling an estimated $38.7K and leaving 1,106 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #171.

Essex LLC first reported a position in IBB in Q3 2021 and has held it in 17 quarters since. The position peaked at $998K in Q1 2022. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Essex LLC held 1,106 shares of iShares Biotechnology ETF worth $210K as of Q2 2026.
  • Essex LLC sold 225 iShares Biotechnology ETF shares in Q2 2026, an estimated $38.7K.
  • iShares Biotechnology ETF made up 0.03% of Essex LLC's portfolio in Q2 2026, its #171 holding.
  • Essex LLC first reported a position in iShares Biotechnology ETF in Q3 2021 and has held it in 17 quarters since.
  • Essex LLC's iShares Biotechnology ETF position peaked at $998K in Q1 2022.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.